Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Sarcoma Channel is supported with funding from Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ESMO Sarcoma and Rare Cancers 2023 | The role of P53 in the early detection of sarcoma

David Thomas, PhD, FRACP, The Kinghorn Cancer Centre, Sydney, Australia, discusses how whole genome sequencing can be utilized to identify p53 mutations that drive the progression of silent sarcomas at early disease stages. Prof. Thomas emphasizes the significance of whole-body MRI in detecting these silent malignancies at a curable stage, whilst also highlighting the prospect of potential blood-based detection strategies to enhance detection and intervention in those at risk. This interview took place at the 2023 ESMO annual Sarcoma and Rare Cancers congress in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.